Mrs Jenna Elizabeth Jordan, PT | |
2620 S Tamiami Trl, Sarasota, FL 34239-4517 | |
(941) 955-1089 | |
Not Available |
Full Name | Mrs Jenna Elizabeth Jordan |
---|---|
Gender | Female |
Speciality | Physical Therapy |
Experience | 25 Years |
Location | 2620 S Tamiami Trl, Sarasota, Florida |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053646828 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 19052 (Florida) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Rick Haupt Physical Therapy Inc | 9335306257 | 5 |
News Archive
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function.
Reducing our cholesterol levels to those of a new-born baby significantly lowers the risk of cardiovascular disease, according to new research.
Cyclacel Pharmaceuticals, Inc. announced today interim response data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes (MDS) that have failed hypomethylating agents. The data were presented at an oral poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 8 days ago
Provider Name | Rick Haupt Physical Therapy Inc |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1508134586 PECOS PAC ID: 9335306257 Enrollment ID: O20120206000192 |
News Archive
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function.
Reducing our cholesterol levels to those of a new-born baby significantly lowers the risk of cardiovascular disease, according to new research.
Cyclacel Pharmaceuticals, Inc. announced today interim response data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes (MDS) that have failed hypomethylating agents. The data were presented at an oral poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Jenna Elizabeth Jordan, PT 4621 Sweetmeadow Cir, Sarasota, FL 34238-4334 Ph: (904) 962-3161 | Mrs Jenna Elizabeth Jordan, PT 2620 S Tamiami Trl, Sarasota, FL 34239-4517 Ph: (941) 955-1089 |
News Archive
Pfizer Canada is pleased to announce that XALKORI (crizotinib) is now available in Canada. Recently approved with conditions by Health Canada, XALKORI is an oral monotherapy for patients with anaplastic lymphoma kinase (ALK)-positive advanced or metastatic non-small cell lung cancer (NSCLC).
Groundbreaking research demonstrates the ability of a specific form of Modified Citrus Pectin (MCP) to greatly enhance immune function.
Reducing our cholesterol levels to those of a new-born baby significantly lowers the risk of cardiovascular disease, according to new research.
Cyclacel Pharmaceuticals, Inc. announced today interim response data from a Phase 2 randomized trial of oral sapacitabine capsules, a novel nucleoside analogue, in older patients with myelodysplastic syndromes (MDS) that have failed hypomethylating agents. The data were presented at an oral poster discussion session at the 2010 American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago, Illinois.
› Verified 8 days ago
The Weston Group Of Florida Inc Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 5311 Proctor Rd, Sarasota, FL 34233 Phone: 941-538-0950 | |
Active Life Therapy Services Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 4000 Sawyer Rd, Sarasota, FL 34233 Phone: 941-586-7110 Fax: 941-921-4820 | |
Kevin Steele, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2055 Wood St Ste 110, Sarasota, FL 34237 Phone: 941-330-1677 Fax: 941-330-1688 | |
Joyce Hegeman, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 1959 N Honore Ave, Sarasota, FL 34235 Phone: 941-462-3980 Fax: 941-371-6827 | |
Michael Ehlers, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 2750 Bahia Vista St, Sarasota, FL 34239 Phone: 941-951-2663 | |
Kyle Backofen, DPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 6150 N Lockwood Ridge Rd, Sarasota, FL 34243 Phone: 941-960-4741 | |
Melissa Guet, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2401 University Pkwy Ste 103, Sarasota, FL 34243 Phone: 941-444-5970 |